Looking for an ADHD Summer Camp or School? Call Toll Free 866.828.1678

Students Suspended for Buying/Selling Adderall

Two Keystone (Lagrange, OH) High School students have been suspended for supposedly buying Adderall from fellow students, the latest in a series of suspensions resulting from the illicit distribution of these drugs.
"The teens received the same punishment as three girls who were accused of selling the drug generally used to treat attention-deficit and hyperactivity to other students earlier this month."
Another student was also suspended for buying the drug. The suspensions will likely lead to expulsions, and the school's assistant principal says his investigation is ongoing. Source: Chronicle-Telegram (OH)

Labels: medications, students, drugs

Posted By: Aspen Education Group 0 Comments

Medications not Linked to Drug Abuse

On Tuesday, researchers from New York University released the results of a study which found no link between ADHD medication and future drug use. The study followed for 17 years 176 young men who had been diagnosed with ADHD and prescribed Ritalin when they were kids (ages 6 or 7).
"Those treated with medications had neither an increased nor decreased risk for subsequent drug or alcohol abuse compared with those not given drugs for their ADHD. 'Considering that ADHD affects 5 to 10 percent of children worldwide, and addictions are worldwide problems as well, I think the fact that these drugs do not have an adverse effect in increasing those risks is very important information for families and doctors...' [Dr. Joseph] Biederman said."
The study did find an increase in later drug use among children who were prescribed medication between the ages of 8 and 12. Researchers speculate, however, that delays in treating ADHD were greater factors for these kids than the medication itself. Source: RehabPub.com.

Learn more about the Impact of ADHD Treatment on Substance Use Disorders
.

Labels: medications, drugs, substance_abuse

Posted By: Aspen Education Group 0 Comments

Role of Stimulants Limited

Professor Joseph Rey from Sydney University has warned that results of recent studies show that neither doctors nor parents should rely on stimulant medication as the primary means of treating ADHD in children. His comments come in the wake of a US study that found little or no long-term difference between kids with ADHD who were treated with stimulant medication verses those who received behavioral therapy treatment.
"Prof Rey said the results of the US National Institute of Mental Health (NIMH) study should change attitudes to ADHD treatment. 'While results of one study rarely justify drastic changes of practice, the findings underscore the complexity of ADHD, show that stimulant drugs are far from being a silver bullet and that there is much we do not yet know,' Prof Rey wrote in the latest Medical Journal of Australia."
Prescribing rates for stimulant drugs have increased nearly ten-fold in the past ten years as ADD and ADHD have become more widely common, but a growing number of doctors and professors are beginning to question medication's long-term benefits. Read more at TheWest.com.au.

Instead of stimulants, what about removing disractions like TV and video games. Stone Mountain School, a therapeutic boarding school for boys, is set in a rustic part of North Carolina that allows boys with ADHD to concentrate on their actions, behaviors, and academics.

Labels: medications, drugs, stimulants

Posted By: Aspen Education Group 0 Comments

Vyvanse Tips

Vyvanse is a new drug intended for treatment of ADD and ADHD. As with any new drug, it can take time to get the dosage just right and learn how it affects your child.
"Always start at the lower dose: 30mg which roughly equals Adderall XR 10mg. They may be on higher doses, even 40mg of the Adderall XR, but always go low and slow. Vyvanse is more efficacious, and if you start at 50mg which roughly equals 20mg Adderall XR, it can bring an unpleasant, intense feeling. Go slowly. The dose equivalents from the studies are often too much in practical use."
Vyvanse is a prodrug which means the delivery system is meant to provide a longer duration of effectiveness. Ideally, it should eliminate the need for an additional dose later in the day.

Labels: medications, drugs

Posted By: Aspen Education Group 0 Comments

Shire Study Suggests Vyvanse May be Effective for Adolescent ADHD Symptoms

Drug manufacturer Shire has released the results of a study aimed at tracking the effectiveness of its drug Vyvanse on adolescents diagnosed with ADHD. Currently, the drug is only approved for treatment of children and adults.

"In this study, Vyvanse improved ADHD symptoms of inattention, hyperactivity and impulsivity in adolescents compared to a placebo," said Ann C. Childress, MD, president of the Center for Psychiatry and Behavioral Medicine, Inc. in Las Vega, Nevada and lead investigator for this study. "These results are important as we look for additional ways to effectively manage ADHD symptoms in adolescent patients." [Source: Shire press release]

As a result of the study, Shire plc has submitted a supplemental New Drug Application (sNDA) to the FDA, requesting that Vyvanse be approved for treatment of ADHD in teenagers. There’s no indication as to when, or if, the application will be approved.


 

Labels: medications, vyvanse, drugs

Posted By: Stefanie Hamilton 0 Comments

ADHD Drug Manufacturer Loses Patent Case

Eli Lilly & Co. has lost a lawsuit aimed at protecting its patent for the ADHD drug Strattera. As a result, it has lowered its earnings expectations for the year.

“The U.S. District Court for the District of New Jersey ruled against the company, saying its method-of-use patent for the drug is invalid. The patent had been set to expire in May 2017. The drugmaker said it plans to appeal the ruling, but noted that it now faces the prospects of potentially having to compete with a generic version of the drug.” [Source: Associated Press]

The ruling opens the door for Eli Lilly competitors to develop and market generic versions of Strattera. In addition to reducing its revenue outlook, the company also announced its intent to cut at least $1 billion of operating costs, including laying off some full-time employees.

Labels: medications, drugs

Posted By: CRC Health Group 0 Comments